Not applicableUnknownNCT05662488
What this trial is testing
FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy
Who this might be right for
Hepatocellular CarcinomaBile Duct Cancer
Peking Union Medical College Hospital 25